Market Tracker

06/23 5:16pm ET

Brainstorm Cell Therapuetics Inc (NASDAQ:BCLI)

4.37
Delayed Data
As of Jun 23
 +0.05 / +1.16%
Today’s Change
2.06
Today|||52-Week Range
5.10
+72.05%
Year-to-Date
No recent news for Brainstorm Cell Therapuetics Inc.

Today’s Trading

Previous close4.32
Today’s open4.28
Day’s range4.21 - 4.37
Volume31,347
Average volume (3 months)201,707
Market cap$81.9M
Dividend yield--
Data as of 4:00pm ET, 06/23/2017

Growth & Valuation

Earnings growth (last year)+41.30%
Earnings growth (this year)-192.59%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book8.25

Competitors

----
ARWRArrowhead Pharmaceut...-0.18-10.40%
HTGMHTG Molecular Diagno...+0.01+0.37%
PRTOProteon Therapeutics...-0.05-3.45%
Data as of 3:59pm ET, 06/23/2017

Financials

Next reporting dateAugust 10, 2017
EPS forecast (this quarter)-$0.15
Annual revenue (last year)$0.00
Annual profit (last year)-$5.0M
Net profit margin--

Profile

Sector
Electronic Technology
Industry
Computer Peripherals
President &
Chief Executive Officer
Chaim Lebovits
Chief Operating &
Medical Officer
Ralph Z. Kern
Corporate headquarters
Hackensack, New Jersey

Forecasts